Safety and Efficacy of Misoprostol versus Oxytocin for the Prevention of Postpartum Hemorrhage
Postpartum hemorrhage (PPH) is the commonest cause of maternal death worldwide. Studies suggest that the use of misoprostol may be beneficial in clinical settings where oxytocin is unavailable. The aim of this study was to compare the safety and efficacy of oxytocin and misoprostol when used in the...
Main Authors: | Rajaei, Minoo, Karimi, Samieh, Shahboodaghi, Zohreh, Mahboobi, Hamidreza, Khorgoei, Tahereh, Rajaei, Farzam |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964754/ |
Similar Items
-
Misoprostol versus High Dose Oxytocin and Laminaria in Termination of Pregnancy in Second Trimester Pregnancies
by: Alavi, Azin, et al.
Published: (2013) -
Efficacy of Rectal Misoprostol for Prevention of Postpartum Hemorrhage
by: Mirteimouri, Masoumeh, et al.
Published: (2013) -
Sublingual Misoprostol versus Intramuscular Oxytocin for Prevention of Postpartum Hemorrhage in Uganda: A Double-Blind Randomized Non-Inferiority Trial
by: Atukunda, Esther C., et al.
Published: (2014) -
Comparison of Sublingual Misoprostol and Intravenous Oxytocin in the Management of Postpartum Hemorrhage After Cesarean Delivery: A Randomized Controlled Trial
by: Nahid Rahbar, et al.
Published: (2018-01-01) -
Modeling maternal mortality in Bangladesh: the role of misoprostol in postpartum hemorrhage prevention
by: Prata, Ndola, et al.
Published: (2014)